Nizatidine 97.0%(HPLC)
97.0%(HPLC)
Properties
| Vapour pressure | 0.0±1.2 mmHg at 25℃ |
| Water Solubility | Slightly soluble |
| Assay Purity | >97%(HPLC) |
| Refractive index | 1.592 |
| B pt. | 478.2±45.0 ℃ at 760 mmHg |
| M pt. | 132℃ |
| Density | 1.249g/cm3 |
Safety Information
| Hazard Statement(s) | H302 |
| Precautionary Statement | P501-P270-P264-P301 + P312 + P330 |
| Symbol |
|
| Signal word | Warning |
| HS Code | 2934999090 |
| Flash point | 243.0±28.7℃ |
| Storage Temp. | '20℃ Freezer |
| Storage Class | 8 |
| Packaging | Glass Bottle |
| UN Number | 2922 |
Description
Recommended products
4-Bromo-3-Methylbenzoic Acid 98%
Application
Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production and is commonly used in the treatment of peptic ulcer disease and gastroesophageal reflux disease. It was developed by Eli Lilly and is marketed under the brand names Tazac and Axid.
Purpose
For R&D use onlynot for drug household or other uses.
General Description
Nizatidine is a histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion.Target Histamine H2 ReceptorNizatidine a selective histamine H2-receptor antagonist is a potent inhibitor of gastric acid secretion with IC50 of 0.9 nM. Nizatidine exhibits maximal inhibition of gastric acid in rats within the first hour of drug administration with EC50 of 1.383 molkg.
Documents
|
COA Not Available |
|
| SDS | |
| COA | |
| Specification | |
| Bulk quote order form |